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ABSTRACT 
Cardiovascular and metabolic disorders are among the main causes of death today. Regular 
exercise can prevent and treat these chronic diseases. A molecule at the center of exercise 
adaptations in skeletal muscle is adenosine monophosphate-activated protein kinase (AMPK). 
Rapid energy turnover in cells, such as during contraction in skeletal muscle, activates AMPK. 
The activation of AMPK leads to inhibition of anabolic processes that consume energy and 
upregulation of catabolic processes that generate energy. AMPK activation increases glucose 
uptake into peripheral tissues. Even insulin-resistant individuals, including type 2 diabetes 
patients, retain the blood-glucose lowering effect of AMPK activation. 
There is a need to better understand how exercise provides protective benefits, and how AMPK 
functions at the cellular level. This thesis consists of three research papers wherein exercise 
and AMPK activation were used as experimental models to identify novel effects of these 
signals in human skeletal muscle. 
The first paper explores how fasting between consecutive bouts of exercise from one day to the 
next enhances the adaptive response. Overlapping fasting with exercise increases AMPK 
signaling and expression of genes that regulate fat oxidation. In addition, the combination of 
exercise and fasting elicits changes in DNA promoter methylation. Fasting overnight between 
an evening and morning training session enhances the adaptive benefits of exercise. 
The second paper investigated if AMPK activation and insulin signaling affect the focal 
adhesion kinase (FAK) in a differential manner in human skeletal muscle. FAK is a necessary 
component for insulin and growth signaling in non-human skeletal muscle models, and cancer 
researchers are exploring FAK inhibitors as cancer therapeutics. The new research provided 
herein demonstrates that insulin does not activate FAK in human skeletal muscle. However, 
AMPK does inhibit FAK. Furthermore, siRNA-mediated silencing of FAK in cells increases 
lipid oxidation. AMPK inhibits FAK, and FAK affects substrate utilization in skeletal muscle 
cells. 
In the final paper, a bioinformatic analysis identified genes that are regulated by AMPK, 
including the gene for ganglioside-induced differentiation-associated protein 1 (GDAP1). 
GDAP1 regulates mitochondrial function in nerve cells. Silencing GDAP1 does not alter 
mitochondrial function or morphology. However, silencing GDAP1 does reduce lipid 
oxidation, non-mitochondrial respiration, and alters the expression of circadian genes. AMPK 
regulates GDAP1 expression, and GDAP1 alters lipid oxidation without affecting 
mitochondrial function in skeletal muscle. 
The key findings of the thesis are; 1) combining fasting with exercise impacts the epigenetic 
state in muscle and induces adaptive changes that promote lipid oxidation, 2) AMPK-mediated 
FAK inhibition may be a therapeutic strategy to treat cells which have a reduced capacity to 
oxidize lipids, and 3) GDAP1 in skeletal muscle plays a role in modulating the core circadian 
clock and non-mitochondrial lipid oxidation. 
SVENSKA SAMMANFATTNING 
Idag dör många människor på grund av hjärt- eller metaboliksjukdomar. Dessa sjukdomar kan 
undvikas och behandlas genom regelbunden fysiskt träning. 
En molekyl som är viktigt för att driva adaptation av skelettmuskel av träning är adenosin 
monofosfat-aktiverat protein kinas (AMPK). AMPK aktiveras när energinivån i en cell är låg. 
När AMPK aktiveras, stängs processer som kräver energi av medan processer som tillverker 
energi aktiveras. En viktig roll för AMPK är att den kan leda till en minskning av blodsocker, 
även i personer med insulinresistans så som patienter med diabetes typ 2. 
Mycket forskning har genomförts om träning och hur AMPK fungerar, men det finns ett behov 
att bättre förstå mekinismer som ger fördelarna från träning. Denna avhandling består av tre 
vetenskapliga projekt där träning och AMPK aktivering användades att identifiera nya effekter 
av dessa signaler i mänsklig skelettmuskel. 
Den första artikel i avhandlingen studerar hur fasta mellan träningstillfällen kan förbättra 
kroppens möjlighet att svara på träningen. AMPK-signalering samt gener som stimulera 
fettoxidering ökade. Metylering av DNA studerades även. 
I den andra artikel studerades om AMPK-aktivering och insulinstimulering påverkar focal 
adhesion kinase (FAK) på olika sätt i mänsklig skelettmuskel. Även om insulinstimulering ökar 
FAK aktivering i andra celler, visar denna forskning att insulin inte aktiverar FAK i human 
skelettmuskel. Vi identifierar även att FAK hämmas när AMPK aktiveras. Slutligen, när FAK-
aktivering minskat genom siRNA transfektion, är fettoxidation höjd. 
I den sista artikel, identifierats nya gener som regleras av AMPK-aktivering. En gen är 
ganglioside-induced differentiation-associated protein 1 (GDAP1), en gen som underhåller 
mitokondriell funktion i nervceller. När GDAP1 hämmas genom siRNA transfektion i humana 
skelettmuskelceller, påverkas inte mitokondriernas form eller funktion. Däremot identifierar vi 
en effekt på gener viktiga för reglering av dygnsrytm och icke-mitokondriell respiration. 
Sammanfattningsvis, 1) att fasta mellan träningstillfällen kommer att öka effekter av träningen 
och påverkar epigenetiska tillstånd i muskel samt transkription och translation av gener viktiga 
för fettoxidering, 2) att hämma FAK genom AMPK-aktivering kan vara en strategi att behandla 
celler med reducerad förmåga att förbränna fett, och 3) i human skelettmuskel spelar GDAP1 
en roll i reglering av dygnsrytm och icke-mitokondriell respiration. 
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1 INTRODUCTION 
1.1 EXERCISE IS MEDICINE 
The leading cause of death globally in 2015 was ischemic heart disease, whereas stroke and 
diabetes were ranked as the second and sixth biggest killers, respectively [1]. Tightly linked 
to these causes of death is the increase in rates of overweight and obesity. Although the global 
population has not doubled since 1979, the prevalence of obesity nearly tripled by 2016, 
affecting over 650 million individuals [2]. The prevalence of type 2 diabetes (T2D) is also 
growing at a startling rate. In 2004, it was projected that one out of every 25 people will be 
diagnosed with diabetes by 2030 [3]. The estimate was updated in 2014 to reflect the growing 
problem; by 2035, one of every 10 people on the planet are projected to have diabetes [4]. 
While reports that rates of T2D have plateaued in the United States must be viewed 
positively, 10% of the US population already has the disease [5]. Simultaneously, rates of the 
condition continue to grow in developing countries [6-8]. Sadly, life expectancy is blunted 
in the presence of diabetes or obesity [9]. Metabolic disorders also lead to a reduction in 
quality of life [10] and an increased financial burden [11].  
A myriad of treatment options exist to ameliorate the multiple burdens of obesity, 
cardiovascular disease, and metabolic disorder. Patients can benefit from surgery, 
prescription medications, altered diet, or adopting a physically active lifestyle depending on 
the severity of their situation. Of these options, exercise may be the most robust intervention 
available to enhance health, since it plays a role in the prevention and treatment in each of 
these conditions, as well as others. 
Regular physical activity is a key component to achieve sustained weight loss [12] and weight 
loss, per se, reduces blood pressure, blood lipids, and plasma glucose in overweight 
individuals [13]. Additionally, regular exercise reduces visceral adipose tissue as compared 
to diet-induced weight loss [14]. The benefits of exercise extend far beyond weight 
maintenance, however. 
In the context of cardiovascular health, a primary benefit of engaging in regular exercise is 
increased maximal cardiac output [15]. Physical activity in older adults is negatively 
associated with cardiovascular events [16] and patients living with coronary heart disease 
have a reduced risk of mortality if they are more active [17]. Compared to age-matched non-
athletes, young and old athletes have higher levels of high-density lipoprotein cholesterol 
(HDL-C), lower levels of low-density lipoprotein cholesterol (LDL-C), and therefore a more 
favorable HDL-C to LDL-C ratio [18]. Cross-sectional data from women and men aged 30–
54 reveal a negative correlation between physical activity and cardiometabolic risk [19]. 
Furthermore, exercise reduces blood pressure —the best single predictor for unfavorable 
cardiovascular events— in those with essential hypertension [20]. Importantly, exercise 
training in patients who previously suffered from heart failure is safe and improves exercise 
capacity [21]. 
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Exercise, while an essential aspect of weight maintenance programs and rehabilitation after 
cardiovascular incidents, also ameliorates the symptoms of metabolic disorders such as T2D. 
Adoption of an exercise routine slows the progression to T2D [22]. With less than 12 weeks 
of training, and before significant changes in weight circumference are achieved, exercise 
leads to a reduction in fasting glucose [23]. Exercise interventions improve the homeostasis 
model assessment-insulin resistance (HOMA-IR) and HDL-C in patients with T2D [24]. 
Increased walking activity, as measured by pedometers or accelerometers, also associates 
with reductions in hemoglobin A1C (HbA1C) in people with T2D [25]. Patients with T2D 
also develop enhanced heart rate variability due to regular exercise [26], which is noteworthy 
since these patients have reduced cardiorespiratory fitness to begin with [27]. 
In instances when lifestyle interventions and pharmacological treatments have insufficiently 
improved the health status of severely obese patients, surgery may be indicated. Roux-en-Y 
gastric bypass (RYGB) results in rapid improvements in body weight and insulin sensitivity, 
with continued improvements extending for at least 24 months [28]. RYGB even outperforms 
intensive lifestyle modifications in reversing T2D [29]. Nonetheless, exercise interventions 
extend the benefits of the surgery. Patients who are more physically active in the months after 
RYGB lose more weight and fat mass [30], have improved insulin sensitivity and HDL-C 
[31], as well as improved cardiorespiratory fitness and mitochondrial respiration [32]. 
Whereas an active lifestyle yields some protection against cardiovascular and metabolic 
disease, a sedentary lifestyle leads to a greater susceptibility to chronic diseases. Drivers of 
double-decker busses in London, who spent their workdays seated, had elevated heart-disease 
incidence and mortality as compared to the busses’ conductors, who regularly walked up and 
down the aisles and stairs to check tickets [33]. More recently, research using pedometers 
and oral-glucose tolerance tests identified a 22% increased odds ratio of T2D per hour of 
sedentary time [34]. Physical inactivity is also correlated to some cancers [35] and depression 
[36]. Scientists use bed rest in research settings to induce skeletal muscle atrophy and to study 
the acute effects of inactivity. Notably, regular resistance exercise minimizes the detrimental 
effects of inactivity on skeletal muscle mass [37]. This effect of exercise is important given 
that there is a negative correlation between mortality and skeletal muscle mass [38]. 
Unfortunately, exercise interventions are not sufficient to overcome all of the harmful effects 
of inactivity on bone density [39], immune cell population [40], markers of liver impairments 
[41], or expression of genes central to an oxidative phenotype in skeletal muscle [42]. 
Inactivity also impairs one’s ability to dispose of a lipid-rich meal, and an acute exercise bout 
is insufficient to recover normal postprandial lipemia [43]. Bedrest impairs insulin sensitivity 
[44] and even lifelong athletes develop reduced glucose tolerance after just 10 days of 
inactivity [45]. A sedentary lifestyle is especially harmful for older adults, since they exhibit 
more atrophy and reduced muscle-protein synthesis compared to younger counterparts when 
subjected to bed rest [46]. An inactive sedentary lifestyle leads to poor health, whereas a 
physically active lifestyle promotes good health.  
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Figure 1: 
The Relationship between Physical Activity and Health 
 
Today, more people are living in countries where overnutrition is deadlier than malnutrition 
[2]. Thus, there is concerted effort among researchers to examine the mechanisms that lead 
to the positive metabolic outcomes associated with physical activity. The first scientific paper 
presented in this thesis explores the hypothesis that exercise and nutrition timing interact to 
modulate metabolic adaptations including DNA methylation. The second and third papers of 
the thesis focus on a key molecule that regulates energetic balance in skeletal muscle during 
exercise: adenosine monophosphate-activated protein kinase (AMPK). In the second paper, 
the hypothesis that AMPK and insulin differentially regulate a growth-promoting protein in 
skeletal muscle is examined. In the final paper, a bioinformatic strategy identifies a new link 
between AMPK and a gene that has surprising effects on skeletal muscle metabolism and 
circadian gene expression. Prior to describing the research methods, a review of metabolic 
flexibility and AMPK is warranted. To conclude the introduction, the aims of the thesis are 
described. 
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1.2 METABOLIC FLEXIBILITY: A PRIMARY ADAPTATION TO EXERCISE 
One of the primary adaptations to repeated bouts of exercise is an enhanced ability of skeletal 
muscle to alternate between lipids and carbohydrates for meeting energy demands. An early 
explanation for the etiology of diabetes mellitus was that an overabundance of lipids inhibit 
carbohydrate oxidation [47].  The ability to adequately alternate between carbohydrate and 
lipid metabolism to meet energy demands is termed metabolic flexibility and an inability to 
switch between these substrates is referred to as metabolic inflexibility [48]. Similar to in 
economic theory, there are elements of supply and demand when it comes to metabolically 
flexibility. During periods of fasting, there is a reduced supply of carbohydrate, and 
metabolically flexible individuals predominantly oxidize stored lipids to sustain biological 
function. In the postprandial period after a meal, metabolically flexible individuals increase 
glucose oxidation in response to elevations in blood sugar and pancreatic insulin secretion [48]. 
On the demand side of the equation, metabolically flexible individuals oxidize lipids to meet 
resting energy requirements. However, in the transition from rest to exercise —and as exercise 
intensity continues to increase— metabolically flexible individuals upregulate carbohydrate 
oxidation, both in absolute and relative terms, to meet the heightened energy needs [49]. The 
workload at which an individual begins using more carbohydrates than lipids to meet energy 
demands is the “crossover” point [50]. 
Researchers can measure consumed oxygen (VO2) and produced carbon dioxide (VCO2) to 
assess which substrates individuals oxidize at a given moment in order to meet energy 
demands. The ratio of VCO2 to VO2 measured by arteriole-venous differences is the respiratory 
quotient (RQ). Indirect calorimetry is a less invasive technique to measure VCO2 and VO2 by 
collecting gasses at the mouth. The ratio of gases measured in this manner is the respiratory 
exchange ratio (RER) and it is a relatively good approximation of RQ. The full chemical 
combustion of a glucose molecule produces the same number of CO2 molecules as O2 
molecules consumed. Thus, an RER of 1.0 is indicative of full reliance on carbohydrate sources 
for energy production. In contrast, it takes 23 molecules of O2 to fully combust a single 
molecule of palmitic acid (the most abundant fatty acid in the body), producing only 16 CO2 
molecules. Accordingly, an RER of 0.7 indicates full reliance on lipid sources for energy 
production. A person has metabolic flexibility if RER is near 0.7 while at rest or in a fasting 
state (when energy supplies and demands are low) but exhibits an RER increase to near 1.0 
after a meal or during intense exercise (when energy supplies or demands are high).  
When RER is measured during insulin stimulation, obese individuals have reduced metabolic 
flexibility as compared to lean individuals [48]. Patients with T2D have reduced free fatty acid 
oxidation in fasting conditions as well as a reduced ability to increase glucose oxidation after a 
meal [51, 52]. In contrast, endurance-trained athletes have a greater capacity to oxidize lipids 
during a hyperinsulinemic/euglycemic challenge as compared to sedentary and obese 
individuals [53]. This observation coincides with others that exercise training enhances lipid 
oxidation at rest and during low intensity exercise [54, 55]. Training increases the reliance on 
lipid oxidation at the same workload due to various adaptations. An increase in maximal VO2 
and mitochondrial enzymes [56] as well as reduced hepatic gluconeogenesis, due to dampened 
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sympathetic nervous system activity [57], both contribute to increased lipid oxidation at low 
exercise intensities. Well-trained individuals also have a capacity to perform at higher absolute 
workloads, which is a direct effect of being able to rely on more carbohydrate oxidation during 
peak performance. The greater capacity to utilize carbohydrates during intense exercise 
observed in athletes is a consequence of greater intramuscular glycogen storage [58], and a 
shift in muscle fibers from IIb to IIa [59] and an increase in the proportion of type I fibers [60-
62]. Lifelong endurance athletes also have more type I fibers than younger athletes [63]. 
Although muscle fibers are categorized based on contractile proteins, an increase in the ratio 
of type I to type IIb fibers is favorable for glucose metabolism since type I fibers have more 
insulin receptors [64] and glucose transporter type 4 (GLUT4) abundance [65]. Due to these 
adaptations to exercise, athletes exhibit enhanced metabolic flexibility while the consequence 
of metabolic disorders is metabolic inflexibility.  
 
Figure 2: 
Metabolic Flexibility is the Capacity to Alternate between Oxidizing Lipids or 
Carbohydrates According to the Supply and Demand of Energy. 
Figure heavily inspired by previous depictions [48, 66]. 
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Nutritional status modulates the improvements to metabolic flexibility induced by training. A 
bout of exercise leads to greater transcriptional activation of genes involved in the adaptive 
response if muscle glycogen is low [67-71]. Unfortunately, low muscle glycogen also blunts 
the capacity to perform high intensity exercise [72, 73]. During exhaustive aerobic activity, 
VO2 remains stable although RQ falls as muscle glycogen is depleted until exercise cannot be 
continued [74]. In order to maximize muscle glycogen, and thereby high-intensity exercise 
performance, endurance athletes have followed various forms of high-carbohydrate diets in the 
days leading up to a competition [58, 74-76]. Alternatively, athletes can prolong high-intensity 
activity if they consume carbohydrates during the exercise [77]. For optimal post-exercise 
recovery, the International Society of Sports Nutrition recommends carbohydrate and protein 
intake in order to maximize glycogen repletion, minimize muscle damage, and maximize 
muscle-protein synthesis in the case of resistance exercise [78]. Although performance suffers 
if one performs exercise while in a fasted and glycogen-depleted state, doing so heightens the 
adaptations that lead to enhanced metabolic flexibility.  
In addition to the changes described above, exercise may alter the epigenetic landscape of 
skeletal muscle. Epigenetic modifications influence gene function without altering the DNA 
sequence and are preserved in daughter cells after mitosis or meiosis. DNA methylation is one 
such modification that alters gene transcription and is the result of cytosine methylation by 
DNA methyltransferases. Germane to this thesis is the finding that exercise modulates DNA 
methylation [79] with subsequent changes in gene expression [80]. In contrasting research, 
12 weeks of exercise training in young and old individuals resulted in only small changes in 
DNA methylation that did not correlate to changes in gene transcription [81]. In another 
multi-omics study, exercise did induce changes to DNA methylation in some genes as well 
as RNA expression of other genes, but the two phenomena did not affect the same genes [82]. 
The most compelling research to date linking exercise to hypomethylation of DNA with 
subsequent increases in mRNA expression gathered samples at several timepoints and linked 
the changes in DNA methylation to exercise intensity [80]. Research by several of the same 
investigators (some of whom are colleagues with the author of this thesis) identified that a 
high-fat diet alters the capacity for exercise to alter DNA methylation [83]. Other research 
studies have found that exercise induces shifts in DNA methylation measured from blood 
samples [84-86]. Changes to DNA methylation in whole blood may be due to altered cell 
population in circulation, rather than changes within individual cells, and may not reflect the 
DNA methylation status of skeletal muscle. There is a lack of consensus regarding how 
exercise modulates DNA methylation in skeletal muscle, and how DNA methylation changes 
affect metabolic flexibility. 
In addition to exercise, caloric restriction enhances the metabolic health and lifespan of 
various non-human organisms, presumably by altering metabolic flexibility. Caloric 
restriction may exert some of its benefits through epigenetic mechanisms, although there is 
a deficit of human research to address this issue [87]. Nonetheless, diet-induced weight loss 
associates with alterations in DNA methylation measured in blood [88]. How fasting and 
exercise interact to alter DNA methylation is unsettled. 
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In light of the research implicating exercise and caloric restriction as modulators of DNA 
methylation and metabolic health, superimposing fasting and exercise bouts may lead to 
augmented adaptations to exercise. Due to the energetic stress induced by superimposing 
exercise and fasting, AMPK signaling may also be upregulated with effects on metabolic 
flexibility. The second and third papers of this thesis explore the role of AMPK in regulating 
skeletal muscle metabolism with an emphasis on identifying new AMPK targets. 
1.3 AMPK: A PROTEIN COMPLEX AT THE CENTER OF ENERGY BALANCE 
ATP hydrolase (ATPase) converts adenosine triphosphate (ATP) to adenosine diphosphate 
(ADP) in an exothermic reaction. If ATP levels are lower than ADP levels, adenylate kinase 
catalyzes the conversion of two ADP molecules to form a single ATP molecule and one 
molecule of adenosine monophosphate (AMP). The breakdown of ATP to ADP or AMP 
releases sufficient energy to drive various cellular processes, and specifically two important 
steps in excitation-contraction coupling: the segregation of Ca2+ ions into the sarcoplasmic 
reticulum via Ca2+ ATPase activity, and the release of myosin from actin filaments by myosin 
ATPase. The high production of AMP during exercise, coupled with the falling levels of 
ATP, leads to activation of AMPK by AMP in skeletal muscle [89]. Additionally, when 
energy levels in the cell are low, liver kinase B1 phosphorylates and activates AMPK [90, 
91]. Calcium flux intracellularly during contraction activates calcium/calmodulin-dependent 
protein kinase kinase 2, which can also phosphorylate AMPK [92]. Because glycogen binds 
AMPK, as exercise persists and intracellular glycogen levels become depleted, AMPK 
molecules are unbound and available for activation [93]. The activation of AMPK in skeletal 
muscle during exercise is adaptive for organisms, since AMPK activity leads to a shift in 
balance of intracellular metabolism away from ATP-utilizing processes toward ATP-
generating processes. 
AMPK activation leads to a net increase in lipid oxidation, a cellular process that generates 
129 molecules of ATP per molecule of palmitic acid catabolized. AMPK phosphorylates 
acetyl-coenzyme A carboxylase (ACC), inactivating the enzyme, and thereby reducing the 
ATP-depleting process of lipogenesis by inhibiting the formation of malonyl-coenzyme A 
(MCoA) [94]. ACC inactivation by AMPK also increases lipid oxidation, since MCoA 
allosterically inhibits carnitine-palmitoyl transferase 1 (CPT1) from importing fatty acids 
into the mitochondria [95]. AMPK activation also activates autophagy by phosphorylating 
Unc-51 like autophagy activating kinase, leading to increases in energy levels by recycling 
lipid and protein from cellular components [96]. 
In addition to its effects on lipid metabolism, AMPK activation enhances glucose uptake. 
Acutely, treatment of human skeletal muscle with an AMPK activator, aminoimidazole-4-
carboxamide ribotide (AICAR) enhances glucose uptake [97]. Glucose uptake is a function 
of cell-surface GLUT4, and the intracellular GLUT4-containing vesicles are mobilized to the 
membrane after inactivation of Rab GTPase-activating proteins including TBC1 domain 
family member 1 (TBC1D1) and TBC1D4 [98, 99]. Exercise-induced AMPK activity 
correlates with inactivating phosphorylation of TBC1D1 and TBC1D4 in human skeletal 
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muscle [100], which indicates that AMPK-dependent phosphorylation of the TBC1 family 
enzymes mediates the increases in glucose uptake induced by AICAR treatment. 
AMPK has important regulatory functions in non-skeletal muscle tissue as well. As little as 
24–48 hours of constitutively active AMPK in rodent liver leads to hypoglycemia and fatty 
liver [101]. These effects are in contrast to what occurs in skeletal muscle, where continuous 
AMPK activity results in increased glycogen storage, an enhanced capacity to oxidize lipids, 
and a greater reliance on lipid oxidation to meet the demands of exercise [102]. An important 
difference between these tissues is that AMPK is activated during fasting in liver [103], but 
not in skeletal muscle [104]. Furthermore, fasting does increase AMPK in the hypothalamus, 
and hypothalamic expression of constitutively active AMPK leads to increased food intake 
and bodyweight [105]. The differential regulation and effects of AMPK across tissues is 
physiologically adaptive; a local low-energy signal induces the brain to increase calorie 
consumption, the liver to release glucose and ketones to the circulation, and the skeletal 
muscle to increase glucose uptake. Thus, AMPK activation in skeletal muscle acutely or 
chronically may enhance whole-body metabolic flexibility, whereas constant stimulation of 
AMPK signaling in other tissues may perturb metabolism. 
Table 1: 
Differential Activation of AMPK According to Stimulus and Tissue 
Stimulus Fasting Contraction 
Tissue Hypothalamus Liver  Skeletal Muscle 
AMPK 
Activity 
↑ ↑ ↔ ↑ 
Effect ↑ caloric intake 
↓ glycogen synthesis 
↓ glycolysis 
↑ ketogenesis 
↔ 
↑ glucose uptake 
↓ fatty-acid synthesis 
Acute 
Result 
↑ blood glucose 
↑ blood glucose 
↑ blood ketones 
↔ ↑ exercise prolongation 
Chronic 
Result 
↑ body weight 
↓ liver glycogen 
↓ blood glucose 
↑ hepatic triglycerides 
↔ 
↑ glycogen storage 
↑ lipid oxidation 
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In skeletal muscle, the long-term effects of AMPK activation on metabolism are due to changes 
in transcriptional activity. AMPK activation leads to an increase in GLUT4 gene expression, 
due to alterations in myocyte enhancer factor-2 binding to DNA [106]. Expression of the 
gene for peroxisome proliferator-activated receptor γ coactivator 1 α (PGC-1α) is also 
enhanced by AMPK activity [107], which leads to an increased abundance of mitochondrial 
proteins [108]. Elevated lipid oxidation subsequent to AMPK activation may also cause 
increases in nicotinamide adenine dinucleotide (NAD+) which is necessary for sirtuin 1 
(SIRT1)-mediated activation of PGC-1α [109]. 
The hypothesis that AMPK activation may increase SIRT1-mediated mitochondrial 
biogenesis is enthralling since mice with overexpression of SIRT1 are protected from 
developing metabolic dysfunction [110, 111]. Mitochondrial function, per se, is associated 
with walking performance in older adults [112, 113], and inversely associated with 
fatigability [114]. Although bodyweight tends to increase over the lifetime, mitochondrial 
respiration is more predictive of body mass index (BMI) than is chronological age [115]. 
Caloric restriction also activates SIRT1 [116], and humans who practice caloric restriction 
have elevated levels of SIRT1 and mitochondrial content in skeletal muscle [117]. In contrast, 
training over 16 weeks —but not caloric restriction— enhances mitochondrial content and 
activity in skeletal muscle, though both interventions improve insulin sensitivity [118]. 
AMPK activity may modulate the beneficial effects of caloric restriction since mice with 
skeletal muscle-specific genetic deficiency of AMPK subjected to caloric restriction actually 
develop impaired glucose tolerance [119]. 
AMPK is a particularly compelling protein to target for pharmacological intervention since 
its activation leads to glucose clearance from the blood, reduced intracellular lipogenesis, and 
increased mitochondrial biogenesis. Patients with T2D exhibit skeletal muscle insulin 
resistance [120]. Importantly, T2D patients retain the ability to increase AMPK-mediated 
glucose uptake [121], and the phosphorylation profile of AMPK and AMPK targets are 
similar between T2D patients and weight-matched controls after exercise or insulin 
stimulation [122]. Medications used to help T2D patients manage their disease also activate 
AMPK including the biguanidines [123, 124] and thiazolidinediones [125]. Even salicylate 
(aspirin) activates AMPK, at least in the liver [126]. 
The capacity for AMPK to induce glucose uptake in an insulin-independent manner deserves 
appreciation since it represents a point of overlap between otherwise opposing catabolic and 
anabolic processes. AMPK activity occurs within cells because of rapid energy depletion. In 
contrast, insulin stimulation occurs physiologically when there is a temporary surplus of 
energy-containing substrates. That both insulin stimulation and AMPK activation increase 
glucose uptake —despite originating from opposite extremes of the energy-availability 
spectrum— would be ingenious, if not for evolution. 
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Figure 3: 
AMPK Activation Induces GLUT4 Translocation Even in the Insulin-Resistant State. 
 
1.4 AIMS OF THE THESIS 
The central theory of this thesis is that exercise drives beneficial metabolic changes in skeletal 
muscle, largely due to AMPK activation. The hypotheses tested were: 
1. Compared to exercising in a glycogen-repleted state, exercising in a glycogen-
depleted state leads to greater AMPK activation, as well as reduces DNA methylation 
and enhances transcription of genes regulating lipid oxidation. 
2. In skeletal muscle, AMPK activation and insulin stimulation antagonistically regulate 
focal adhesion kinase (FAK), a protein regulating cell growth and motility. 
3. AMPK activity inhibits the expression of the gene coding for ganglioside-induced 
differentiation-associated protein 1 (GDAP1) in skeletal muscle, and this gene plays 
a role in maintaining mitochondrial function. 
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2 METHODS 
2.1 HUMAN SUBJECTS 
This thesis reports data from three groups of men who donated skeletal muscle tissue after 
giving informed consent. In the first study, seven Australian endurance athletes participated in 
an exercise and diet protocol. In the second paper, 11 healthy Swedish men donated skeletal 
muscle biopsies for use in research using ex vivo stimulation. In the final paper, archived 
samples from subjects that in previous research were analyzed [127]; specifically, 12 T2D 
patients and 12 controls with normal glucose tolerance donated biopsies at rest, immediately 
after exercise, and three hours later. 
Table 2: 
Participant Characteristics for Papers 1 and 2 
 
Paper 1 Paper 2 
Age (years) 29 ± 5 50.6 ± 2.4 
Body mass (kg) 76.9 ± 9.1 81.4 ± 3.3 
Height (cm) Not measured 179.9 ± 2.4 
BMI (kg/m2) Not measured 25.1 ± 0.6 
Waist-to-hip-ratio Not measured 0.89 ± 0.01 
VO2Peak (mL/kg/min) 6.07 ± 4.0 Not measured 
Peak power output (W) 422 ± 39 Not measured 
Systolic blood pressure (mmHg) Not measured 125.0 ± 3.9 
Diastolic blood pressure (mmHg) Not measured 79.5 ± 1.8 
Fasting plasma glucose (mmol/L) Not measured 5.3 ± 0.1 
Fasting insulin (pmol/L) Not measured 49.9 ± 7.9 
HbA1C (%) Not measured 5.3 ± 0.1 
HbA1C (mmol/mol) Not measured 34.5 ± 0.9 
HDL-C (mmol/L) Not measured 1.3 ± 0.1 
LDL-C (mmol/L) Not measured 3.9 ± 0.1 
Total cholesterol (mmol/L) Not measured 5.7 ± 0.1 
Triacylglecerol (mmol/L) Not measured 0.9 ± 0.2 
All values reported as mean ± standard deviation.  
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Table 3: 
Participant Characteristics for Paper 3 
 Normal Glucose Tolerance Type 2 Diabetes 
Age (years) 59 ± 2 58 ± 2 
Body mass (kg) 84.8 ± 3.4 86.4 ± 4.1 
Height (cm) 179 ± 2 177 ± 2 
BMI (kg/m2) 26.4 ± 1.0 27.6 ± 1.0 
Body fat (%) 27 ± 2 30 ± 2 
VO2Peak (mL/kg/min) 39.3 ± 2.35 32.2 ± 2.83 
Peak power output (W) 253 ± 14 188 ± 16* 
Peak heart rate (beats/min) 169 ± 3 166 ± 5 
Systolic blood pressure (mmHg) 127 ± 4 131 ± 4 
Diastolic blood pressure (mmHg) 79 ± 2 81 ± 3 
Fasting plasma glucose (mmol/L) 5.0 ± 2.2 7.7 ± 0.5* 
2 hour plasma glucose (mmol/L) 5.6 ± 0.5 14.3 ± 1.1* 
Fasting insulin (pmol/L) 42.4 ± 6.3 68.8 ± 7.6* 
HOMA-IR 1.38 ± 0.24 3.30 ± 0.53* 
HbA1C (%) 5.3 ± 0.1 6.6 ± 0.3* 
HbA1C (mmol/mol) 35 ± 1 49 ± 3* 
HDL-C (mmol/L) 1.39 ± 0.12 1.22 ± 0.08 
LDL-C (mmol/L) 3.24 ± 0.18 2.15 ± 0.19* 
Total cholesterol (mmol/L) 5.07 ± 0.21 3.94 ± 0.20* 
Triacylglecerol (mmol/L) 0.96 ± 0.10 1.26 ± 0.16 
All values reported as mean ± standard deviation. 
* Indicates significant difference between groups by an unpaired t-test 
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2.2 EXERCISE AND DIET INTERVENTIONS 
For the first paper of this thesis, participants visited the research facility for two overnight 
experimental trials in a randomized crossover design. In both trials, participants consumed 
standardized meals, engaged in an exercise bout, stayed overnight in the laboratory, and 
engaged in a second exercise bout on the second day. In one arm of the crossover design, 
participants did not receive calories between the exercise bouts. In the other arm of the study, 
participants ingested calories in between the exercise bouts before going to sleep on the first 
day of the visit. The amount of food given to participants was isocaloric and had the same 
macronutrient profile between the visits. The experimental manipulation was whether 
participants received all of their calories before the first exercise bout on the first day, or if the 
calories split and instead ingested before and after the first exercise bout. In both arms of the 
study, participants donated blood that was later analyzed for changes in metabolic substrates 
and hormones. Participants also donated muscle biopsies that were rapidly frozen, and then 
split into aliquots for subsequent analysis. Biopsies were analyzed for changes in protein 
abundance and signaling by Western blot analysis, as well as for changes in gene expression 
using reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Other aliquots 
of the biopsies were used to interrogate changes in DNA methylation in promoter regions of 
key metabolic genes. 
For the second paper of the thesis, participants reported to the laboratory after an overnight fast 
to donate muscle biopsies from vastus lateralis. The participants in that research did not engage 
in other diet or exercise interventions. 
For the third paper of the thesis, gene expression of GDAP1 was measured in the vastus 
lateralis from T2D patients or individuals with normal glucose tolerance before and after an 
exercise bout. Other data from these participants has previously been reported [127]. 
Participants in the study donated a vastus lateralis muscle biopsy after an overnight fast (and 
abstention from metformin in the T2D group). The participants returned to the laboratory at 
least five days later and donated two additional muscle biopsies, immediately after 30 minutes 
of exercise and three hours later. The biopsies were subsequently processed for analysis of gene 
expression by RT-qPCR. 
2.3 DNA METHYLATION 
In the first paper of the thesis, the DNA methylation status of genes regulating metabolic 
function was interrogated. A literature search identified candidate genes and specific promoter 
regions for examination. A commercially available kit extracted DNA from the muscle 
biopsies. An enzymatic reaction bisulfite-converted the DNA, leading to conversion of 
unmethylated cytosines to uracils. 
A polymerase chain reaction (PCR) with custom-designed oligonucleotides amplified the 
regions of interest identified from the literature search. The custom oligonucleotide targeting 
the reverse strand of bisulfite-converted DNA contained a biotin tag at the 5’ end, which was 
necessary for successful execution of downstream pyrosequencing. 
 14 
Visual inspection of an aliquot of amplified DNA on an agarose gel cast with a fluorescent 
nucleic acid dye exposed to ultraviolet light verified amplification and specificity of the PCR. 
The amplified DNA was pyrosequenced and the proportion of methylated cytosines in the 
genomic DNA was determined by calculating the ratio of cytosines to tyrosines at each variable 
locus. 
2.4 RT-QPCR 
All three papers of this thesis utilize gene expression as a readout. Commercially available kits 
extracted RNA into water. Concentrations of RNA in different samples were determined via 
spectrophotometry. Reverse transcription (RT) was used to generate cDNA by loading reaction 
tubes with equal concentrations of RNA for samples from the same experiment. After cDNA 
synthesis, a portion of each sample was pooled so as to make a sample which would be used to 
construct a standard curve for the quantitative PCR (qPCR) step to come. A serial dilution of 
the pooled sample was used to make the points of the standard curve. All other samples were 
diluted 20-fold so as to minimize the effects of RT reagents in the subsequent qPCR. Custom-
designed oligonucleotides were mixed with the samples and SYBR green reagents (Thermo 
Fisher Scientific, Waltham, MA) drove the qPCR. Specificity of oligonucleotides was verified 
by conducting a melt-curve analysis after the qPCR. In addition to candidate genes, reference 
genes were also analyzed in a separate qPCR. All data reported in the papers have been 
normalized to the abundance of reference genes. 
2.5 WESTERN BLOT ANALYSIS 
To investigate alterations in protein abundance and signaling, Western blot analysis was used 
in all three papers. Skeletal muscle biopsies from humans, whole muscle from mice, or primary 
human skeletal muscle cells were homogenized in a buffer containing protease inhibitors. 
Samples were centrifuged and supernatants separated from the debris pellet formed during 
centrifugation. A portion of the supernatant was used for quantifying protein concentration 
using a colorimetric Bradford assay or bicinchoninic acid assay. 
Samples were diluted in reducing Laemmli buffer to equal concentrations and heated to 57°C 
for 20 minutes or longer. Equal volumes of samples were loaded into precast gels and sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis was performed. Proteins were transferred 
from gels to polyvinylidene difluoride (PVDF) membranes by electroblotting. PVDF 
membranes were reversibly stained with Ponceau S stain to assess equal loading of lanes with 
samples qualitatively. The Ponceau S stain was removed by raising the pH using repeated 
washes with pH 7.6 tris-buffered saline with Tween-20 (TBST). 
To prevent non-specific binding of antibodies in subsequent steps, membranes were blocked 
in 7.5% non-fat dry milk in TBST. The membranes were exposed to primary antibodies 
targeting specific proteins of interest overnight at 4°C. The following day, membranes were 
washed several times in TBST and then exposed to horseradish-peroxidase (HRP) conjugated 
secondary antibodies specific to the primary antibodies used in the previous overnight 
incubation. The secondary antibody treatment was conducted at room temperature for at least 
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one hour. Membranes were washed several times in TBST and then treated with enhanced 
chemiluminescence (ECL) substrate. Because the HRP and ECL chemically reacted to 
generate light, the membranes were then transferred to a darkroom and exposed to x-ray film. 
The x-ray film was developed in the darkroom and subsequently scanned on a flatbed scanner 
suitable for image acquisition to permit downstream densitometry. The scanned images were 
used to quantify optical density of bands on the x-ray films according to which sample to which 
they corresponded. Molecular ladders were used when loading the polyacrylamide gels and 
marked on the x-ray films for orientation. Images that were overexposed were not used for 
quantification. 
2.6 EX VIVO STIMULATION OF HUMAN SKELETAL MUSCLE BIOPSIES 
In the second paper of the thesis, a previously developed open-muscle biopsy technique [128-
130] was used to study the influence of insulin- and AICAR-stimulation on FAK 
phosphorylation in human skeletal muscle. The technique was undertaken under aseptic 
conditions. After local delivery of anesthetics to vastus lateralis muscle of volunteers, a 
surgeon made an incision through the skin and fascia to reveal the skeletal muscle tissue. The 
skeletal muscle was clamped at resting length, and muscle fibers were dissected out and 
transferred to oxygenetaed Krebs-Henseleit bicarbonate buffer that was supplemented with 
mannitol and glucose. 
The fibers were transported from the hospital to the research facility where they were then 
trimmed of connective tissue and mounted on Plexiglass clips as strips approximating one 
centimeter in length. The muscle strips had a final weight of ~20 milligrams. Muscle strips 
were incubated for 30 minutes in a recovery buffer, 20 minutes in a treatment buffer containing 
insulin or AICAR, 10 minutes in a glucose-free rinse buffer, and finally 20 minutes in a buffer 
containing 14C-labeled mannitol and 3H-labeled 3-O-methylglucose. The muscle strips were 
subsequently frozen in liquid-nitrogen cooled clamps and saved for later analysis. 
The gene expression of these strips was not explored in this thesis, but has been explored in 
another publication [131]. In this thesis, protein signaling and glucose transport were assessed 
by Western blot analysis and scintillation counting of radioactive isotopes, respectively. 
Specifically, scintillation counting of 3H and 14C revealed how much 3-O-methylglucose and 
mannitol was taken into the fibers, respectively. Because mannitol cannot be taken up by intact 
muscle cells, the difference in the concentrations calculated from the scintillation counts was 
used to infer how much 3-O-methylglucose was taken up by the cells. 
2.7 GENETICALLY MODIFIED MICE 
To assess how AMPK activity influences GDAP1 expression in skeletal muscle, two different 
strains of genetically modified mice previously developed were used for the third paper of the 
thesis [132]. Both strains of mice have altered functionality of AMPK due to genetic 
manipulations of the γ3 subunit, which is predominantly expressed in skeletal muscle. One 
strain of mice has a deletion in the coding region for AMPKγ3, resulting in reduced AMPK 
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activity in skeletal muscle. The other strain has a transgene with a mutation causing an arginine 
to a glutamine switch at amino acid 225 in the translated polypeptide, resulting in an AMPK 
protein that is constitutively active due to an inability to take an inactive conformation. The 
strains are referred to as AMPKγ3-/- and AMPKγ3R225Q, respectively. 
In the third paper of the thesis, mice with these genetic modifications, and their respective wild-
type littermates, were given free access to food or subjected to an overnight 12-hour fast. 
Following the overnight period, blood glucose was sampled from the tail, mice were 
anesthetized, and gastrocnemius tissues were harvested. Gene expression was measured by 
RT-qPCR as described earlier in this thesis. 
2.8 PRIMARY HUMAN SKELETAL MUSCLE CELL CULTURE 
The use of primary human skeletal muscle cells was central to the final two papers of the thesis. 
Primary cells used in the second paper were isolated from skeletal muscle tissue unused in the 
glucose transport assay described earlier. The primary cells used in the third paper were 
prepared and described by the research previously [133]. The satellite-cell isolation technique 
has been described [134]; biopsies were digested with collagenase and trypsin, supernatant 
containing satellite cells and fibroblasts were harvested and added to a petri dish for one hour 
to select against adherent fibroblasts, and the supernatant was finally collected from the dish to 
retrieve the satellite cells. 
When primary human skeletal muscle cells were used in the thesis, satellite cells were grown 
and differentiated into myotubes according to methods described elsewhere [131]. Briefly, cells 
were seeded in uncoated plates or dishes and incubated at 37°C in the presence of a growth 
medium containing 20% fetal bovine serum (FBS). Once cells reached ~80% confluence, 
differentiation was induced by switching to a medium containing 2% FBS, 100 µg/mL 
apotransferrin, and a high dose of insulin (1.7 µM). Cells were incubated in this differentiation 
media for ~96 hours prior to being switched to an insulin-sensitizing media that was insulin-
free. Experiments were carried out after ~96 hours in the final media. In all steps of cell growth 
and differentiation, cells received fresh media every 2–3 days. 
2.9 GENE SILENCING IN CELLS 
Manipulating gene expression in primary skeletal muscle cells was a central experimental 
technique used in the second and third papers of the thesis. Lipofection was utilized to deliver 
siRNA to cells in order to silence genes of interest as described elsewhere [135]. Specifically, 
cells were transfected on the first day of incubation with the low-insulin post-differentiation 
media, and again ~48 hours later. Final experiments were carried out ~48 hours after the second 
transfection. In all transfection experiments, cells were transfected with either siRNA directed 
against the gene of interest or a negative control siRNA. 
2.10 METABOLIC PHENOTYPING OF CELLS 
After silencing genes of interest, the metabolic phenotype of the primary human skeletal muscle 
cells was investigated in the final two papers of the thesis. Assays for palmitate oxidation and 
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glycogen synthesis were performed for both papers. For the final paper, assays assessing 
glucose oxidation, glucose uptake, lactate production, and mitochondrial function were also 
performed. 
To assess palmitate oxidation, cells were incubated with 3H-labeled palmitic acid in the 
presence of AICAR or differing doses of glucose. As the cells oxidized the palmitate, the 3H 
was incorporated into water and released from the cells. Supernatant from the cells was 
harvested and separated from the palmitate with activated charcoal. The palmitate-free 
supernatant was then subjected to scintillation counting to assess palmitate oxidation. 
Glycogen synthesis was assessed by exposing serum-starved cells to 14C-labeled glucose in the 
presence of different doses of insulin. Cells were lysed, glycogen was precipitated and finally 
subjected to scintillation counting. 
Like the glycogen synthesis assay, 14C-labeled glucose was the tracer used to assess glucose 
oxidation. As the cells oxidized glucose, they released radiolabeled-CO2 into the media. To 
capture the released CO2, a small plastic cup was placed gently on top of the cells and cell 
plates were sealed with airtight plate sealers. After four hours of glucose oxidation, a 
hypodermic needle was used to deliver NaOH through the plate seals and into the plastic cup. 
Immediately after, HCl was delivered to the cell media, causing a drop in pH and consequently 
a release of CO2 into the air above the media. By the law of mass action, the CO2 in the air 
accumulated into the NaOH. After one hour, the plates were opened and the small plastic cups 
were transferred to scintillation vials for quantification of radioactivity. 
The glucose uptake assay was conducted as previously described [135]. Cells were incubated 
for 1 hour in a glucose- and serum-free media prior to a 15-minute exposure to 2-[1,2-
3H]deoxy-D-glucose. This glucose analog can be taken up by the cells and phosphorylated by 
hexokinase, but is not further metabolized. Cells were rinsed with ice-cold phosphate-buffered 
saline (PBS), and lysed. Lysed cells were used in scintillation counting to determine glucose 
uptake. 
The media from the one-hour incubation of cells in the glucose- and serum-free media in the 
glucose uptake assay was collected to assess lactate production. A colorimetric assay was used 
wherein lactate dehydrogenase converted lactate to pyruvate and NAD+. The NAD+ could be 
detected by spectrophotometry and used to infer lactate production by the cells [136]. 
Mitochondrial function of cells was assessed by subjecting them to a stress test and measuring 
oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) by using a 
Seahorse analyzer (Santa Clara, CA). The analyzer measures OCR and ECAR via probes that 
detect changes in O2 tension and pH in each well of a 24-well cell-culture plate. Additionally, 
the analyzer has several injection ports that allow for the timed delivery of different compounds 
to the cells in order to study how the cells respond due to various treatments. In the 
mitochondrial stress test, OCR and ECAR were measured at three timepoints prior to any 
pharmacological stimulation in order to establish baseline readings. Oligomycin, an ATP 
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synthase inhibitor, was then injected. After three more readings, carbonyl cyanide-4-
(trifluoromethoxy)phenylhydrazone was injected to uncouple proton flow from ATP synthesis 
in mitochondria. Three more readings were taken before an injection of rotenone and antimycin 
A, which block the electron transfer of mitochondrial complexes I and III to ubiquinone, 
respectively. A final three readings were made of OCR and ECAR before terminating the 
experiments. The alterations in OCR and ECAR under different conditions permitted the 
calculation of multiple parameters of mitochondrial function and oxidative metabolism in the 
cells. 
All of the metabolic assays conducted in the cells were normalized to protein content as 
measured by a colorimetric Bradford assay or bicinchoninic acid assay. 
2.11 CONFOCAL MICROSCOPY 
Confocal microscopy was used to examine the effects of silencing GDAP1 expression on 
mitochondrial structure in primary skeletal muscle cells. Approximately 48 hours after the final 
transfection of siRNA, cytoplasm, nuclei, and mitochondria were stained using protocols 
recommended by the dyes’ manufacturers. After staining, cells were fixed by treating with 
3.7% formaldehyde for 20 minutes and then washed several times with PBS.  
Blue-fluorescing cell nuclei were located through the eyepiece of a confocal microscope using 
a 40X-magnification objective while exciting the Hoechst dye fluorophores using light at 361 
nm λ. Next, simultaneous excitation of the nuclear dye and the mitochondrial dye was 
accomplished by stimulating with light at two wavelengths (361 nm λ and 644 nm λ). Software 
translated the emitted light (486 nm λ and 665 nm λ, respectively) into blue and white on a 
computer monitor, and focus was manually adjusted. A three-by-three tiling array of images 
was made by the software in order to get an overview of the cell population. 
From the overview picture, at least four fused myotubes were selected for obtaining more-
detailed images. The software moved the confocal microscope to the x,y-coordinates of the 
selected myotubes and focus in the z-axis was adjusted manually. Individual images of nuclei, 
cytoplasm, and mitochondria were obtained from each of the saved x,y,z-coordinates by 
sequentially exciting fluorophores with respective light sources and capturing emitted light in 
the appropriate range. A final overlay image was made by superimposing the three separate 
images obtained. 
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Figure 4: 
Confocal Microscopy of Primary Human Skeletal Muscle Cells 
Clockwise from bottom left: Nuclei, Mitochondria, Cytoplasm, and Overlay. 
Scale bar is 20 µm. 
 
To analyze the data, only the nuclei and mitochondrial networks were superimposed in a 
selection of images. These images were coded to mask the treatment associated with each 
image. Images were sent to collaborators who were assigned the task of determining if there 
were consistent qualitative differences between treatment groups in terms of mitochondrial 
network morphology. If there was consensus among the blinded researchers regarding 
mitochondrial network morphology according to experimental conditions, quantitative analysis 
would have been warranted and a non-biased method of obtaining images and quantifying 
mitochondrial structures would have been developed. 
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2.12 BIOINFORMATIC ANALYSIS AND USE OF PUBLIC DATA 
The primary hypothesis for the third paper of the thesis was that overlaying data from publically 
available microarray studies would successfully identify genes regulated by AMPK activity. 
Data from three experiments reported in two publications were used to generate a list of 
candidate genes [137, 138]. The microarrays used to identify candidate genes were generated 
by experimentally manipulating AMPK activity in mouse skeletal muscle by injections with 
AICAR [137] or through genetic modifications to AMPK [138], previously described in this 
thesis [132]. To identify the candidate genes, expression analysis from the three datasets was 
normalized by the robust multi-array averaging (RMA) method [139]. The RMA method 
enables comparisons of gene expression between microarray studies by transforming the reads 
across all datasets to fit on the same scale. Candidate genes thought to be increased by AMPK 
activity were identified if they were significantly increased in all models of increased AMPK 
activation and significantly decreased in the model of AMPK inhibition. In contrast, candidate 
genes thought to be negatively regulated by AMPK activity were identified if they were 
significantly decreased in all models of AMPK activation and significantly increased in the 
model of AMPK inhibition. 
The gene expression omnibus (GEO) and genome-wide association studies (GWAS) catalog 
were two other publically available tools used to investigate the role GDAP1 plays in metabolic 
disorder [140, 141]. The GEO helped to identify research studies where GDAP1 expression 
was reduced in mouse skeletal muscle due to acute fasting and lifetime caloric restriction [142, 
143]. The GWAS catalog identified a dozen publications linking single-nucleotide 
polymorphisms in the GDAP1 gene to signs or symptoms of metabolic disorder including waist 
circumference, blood pressure, and circulating fatty acids [144-155]. 
2.13 DATA ANALYSIS AND STATISTICS 
In the second and third papers of the thesis, all inferential statistics were conducted using R, an 
open-source free-to-use computer programming language [156]. Several add-on libraries also 
facilitated data processing and analysis: “openxlsx” for reading and writing files to Microsoft 
Excel [157], “magrittr” and “tidyverse” for writing code in an easy-to-read manner and 
visualizing data [158, 159], and “ez” and “lawstat” for conducting inferential statistics [160, 
161]. In the first paper, inferential statistics were performed using other commercial software, 
but the data interpretations for the DNA-methylation results were crosschecked by using R. In 
all papers, α was set to 0.05. 
The data analysis consisted of first identifying which kind of parametric omnibus test was most 
appropriate for the study design (e.g., a t-test in a simple design or a 2-way mixed-model 
analysis of variance (ANOVA) in a more complex study design). After identifying which 
omnibus test was most appropriate, the assumptions of the specific test were identified and 
tested. When the assumptions were violated, if adjustments could be made to the omnibus test 
to correct for violations, adjustments were made. If adjustments could not be made because of 
the violated assumptions, an alternative non-parametric omnibus test was employed instead. 
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For example, in the case of a two-way mixed-model ANOVA, there are seven assumptions to 
test for before interpreting p-value outputs of the statistical test [162]. Three of these 
assumptions are regularly passed over by researchers: 1) the assumption that the dependent 
variable is normally distributed for each group analyzed (e.g., each combination of the two 
factors in the two-way mixed-model ANOVA), 2) the assumption that there is homogeneity of 
variance for each combination of the groups (also known as homoscedasticity), and 3) the 
assumption that the variances of the differences between the related groups of the within-
subjects factors for all groups of the between-subjects factor is equal (this is also known as 
sphericity). In this thesis, when the assumption of normality was to be tested, a Shapiro-Wilk 
test was used. To test for homogeneity of variance, Levene’s test was used. A Mauchly’s test 
was used for assessing if the assumption of sphericity was violated. In cases where the 
assumption of normality could not be reasonably kept (i.e., Shapiro-Wilk’s test yielded p < 
0.05), a non-parametric omnibus test was selected to analyze the data. If Levene’s test was 
significant, a White adjustment was made. If a Mauchly’s test was significant, a Greenhouse-
Geisser correction was made if the test statistic ε < 0.75, and a Huynh-Feldt correction was 
made otherwise. 
Pairwise post-hoc tests were conducted with equal consideration for violations of test 
assumptions. The risk of reporting false-positive results was reduced by using the Benjamini-
Hochberg false-discovery rate correction when interpreting the p-values from multiple post-
hoc tests. 
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3 RESULTS 
3.1 PAPER 1: EFFECTS OF SLEEPING WITH REDUCED CARBOHYDRATE 
AVAILABILITY ON ACUTE TRAINING RESPONSES 
The primary finding from the first paper was that exercising while in a fasted state the morning 
after a glycogen-depleting exercise bout enhances the capacity of skeletal muscle to oxidize 
fats by increasing mitochondrial protein abundance and expression of genes involved in lipid 
oxidation. Specifically, the fasting protocol superimposed onto the exercise bouts led to 
increases in AMPK activity —as evidenced by increased phospho-AMPKThr172 and phospho-
ACCSer222— as well as the abundance of CPT1, and adipose triglyceride lipase. The genes for 
pyruvate dehydrogenase kinase 4 and fatty-acid binding protein 3 (FABP3) were also increased 
due to fasting. DNA methylation on the promoter for the FABP3 gene tended to be decreased 
under the fasting state. Peroxisome proliferator-activated receptor delta expression was not 
significantly impacted due to fasting, although there was significantly increased DNA 
methylation in the promoter at the final timepoint. Together, these results demonstrate that 
combining exercise and fasting augments the adaptive response to exercise.  
3.2 PAPER 2: FAK TYROSINE PHOSPHORYLATION IS REGULATED BY 
AMPK AND CONTROLS METABOLISM IN HUMAN SKELETAL MUSCLE 
The hypothesis for the second paper was that insulin- and AMPK-stimulation would regulate 
FAK activity in opposing manners in human skeletal muscle. Surprisingly, an increase in 
phospho-FAKTyr397 due to insulin stimulation was not observed, although this effect occurs in 
other models. However, AICAR treatment did reduce phospho-FAKTyr397 in human skeletal 
muscle biopsies treated ex vivo. AICAR and serum-starvation also lead to decreases in 
phospho-FAKTyr397 that were inversely correlated with phospho-ACCSer222. Reducing FAK 
activity by silencing its gene, PTK2, increases lipid oxidation and decreases glycogen synthesis 
in primary human skeletal muscle cells. Silencing PTK2 did not alter AICAR-stimulated 
changes in phospho-ACCSer222 nor insulin-stimulated changes in phosphorylation of protein 
kinase B. These data reveal that, in human skeletal muscle, FAK is an AMPK-regulated protein 
that controls fat oxidation. 
3.3 PAPER 3: LIPID OXIDATION IN SKELETAL MUSCLE IS IMPAIRED DUE 
TO GDAP1 SILENCING, AN AMPK-REGULATED GENE 
In the final paper, GDAP1 was identified as an AMPK-regulated gene that plays a role in lipid 
oxidation. A bioinformatic analysis revealed GDAP1 as a gene under the control of AMPK. 
Validation experiments showed that GDAP1 expression in skeletal muscle inversely correlates 
to AMPK activity. Furthermore, silencing GDAP1 in primary skeletal muscle cells reduces 
lipid oxidation as well as non-mitochondrial respiration. Finally, AMPK activation and 
silencing GDAP1 independently alter the expression of circadian genes. Unlike in nerve cells, 
GDAP1 expression in skeletal muscle cells does not appear to alter mitochondrial form or 
function. In summary, GDAP1 is regulated by AMPK in skeletal muscle, plays a role in non-
mitochondrial metabolism, and interacts with the circadian machinery.  
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4 DISCUSSION 
It has been recognized for centuries, if not millennia, that exercise is essential for wellbeing. In 
the 1700s, the “father of orthopedics”, Nicolas Andry de Boi-Regard, theorized that exercise 
enhances health [163]. Socrates, the ancient Greek philosopher, also recognized that 
maintaining physical fitness was key to maintaining health, happiness, and preparedness for 
life’s struggles [164]. Even more-ancient non-Occidental traditions have emphasized physical 
activity as a matter of course, and this is echoed in today’s manifestations of yoga and other 
reverent exercise practices. Among the beneficial effects of exercise is its capacity to 
profoundly improve the metabolic health of individuals.  
The research conducted in the past decades has begun to reveal the mechanisms responsible 
for the metabolic improvements induced by exercise. Among the important discoveries has 
been that AMPK is activated due to rapid energy turnover in cells, and is a key driver for 
adapting to exercise. Additionally, because AMPK activation increases glucose uptake —even 
in insulin-resistant patients [121]— investigation of this protein is a central focus in metabolic 
research. However, the physiological and molecular processes involved in exercise adaptation 
and AMPK activation are still incompletely resolved. 
The work in this thesis is directed toward revealing previously undescribed effects of exercise 
and AMPK activation in human skeletal muscle. First, a novel strategy to enhance exercise 
adaptations by fasting between training sessions is investigated. Second, a role for AMPK to 
inhibit the activity of FAK in skeletal muscle is described. Finally, GDAP1 is identified as an 
AMPK-regulated gene that plays a role in non-mitochondrial lipid oxidation and the circadian 
rhythm of skeletal muscle cells. Each of the papers presented in this thesis further contribute to 
the field of metabolic research. 
4.1 PAPER 1: PROS AND CONS OF FASTING AFTER TONIGHT’S EXERCISE 
TO ENHANCE THE EFFECTIVENESS OF TOMORROW’S WORKOUT 
Markers of endurance training are acutely upregulated if carbohydrates are restricted for the 
three-hour timeframe after exercise [165], and the transcriptional response to exercise is 
intensified if skeletal muscle glycogen stores were previously depleted [68, 69, 71]. The 
results described from the first paper in the thesis are in agreement with this previous 
research. The earlier studies reported that repeated exercise bouts conducted in the same day 
enhance the adaptive response due to low skeletal muscle glycogen. The new results from 
this thesis reveal that individuals may split two workouts between an evening session and a 
morning session while still gaining the adaptive benefits, so long as calories are restricted 
between the exercise bouts. Fasting between the exercise bouts also leads to changes in DNA 
methylation in targeted genes, which may alter transcriptional activity. 
A similar intervention paradigm was extended over a three-week period in follow-up research 
[166]. That research revealed that regular engagement in morning exercise in the glycogen-
depleted state after an exercise bout the day before led to enhanced performance on measures 
of endurance as well as reduced fat mass [166]. In the follow-up research, it was reported 
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that sleep quality was not negatively impacted by sleeping with low glycogen stores over the 
three-week period [167]. However, it was not a crossover study, and the authors report data 
indicating that before the intervention began, the group of individuals in the low-glycogen 
arm of the study had greater sleep efficiency and more sleep time as compared to individuals 
in the control group. More importantly, the low-glycogen group did exhibit reduced sleep 
efficiency while engaging in the diet intervention. Abstention from carbohydrates after an 
evening exercise does enhance the adaptive response elicited from a training session 
conducted the following morning, but it may also impair sleep quality. 
The benefits of late-day exercise and fasting must be carefully weighed against potential 
drawbacks. Longer periods of uninterrupted sleep are associated with reduced blood sugar 
levels [168]. Experimentally misaligning the circadian rhythm by shifting light exposure in 
humans by 12 hours impairs glucose tolerance and insulin sensitivity [169]. Additionally, 
variations in the melatonin receptor 1B gene associate with hyperglycemia in bipolar patients 
[170]. Given that perturbations to normal circadian function negatively affect glucose 
homeostasis, the fasting and exercise paradigm used to enhance skeletal muscle adaptations 
may be contraindicated if it leads to impaired sleep quality. 
In light of these negative consequences on glucose homeostasis by disrupted sleep and 
circadian rhythm, alternatives to fasting after an evening exercise bout may be preferred to 
elicit the beneficial effects of training with low muscle-glycogen content. Prescribing caloric 
restriction by 25% over a two-year period led to reductions in body weight without negatively 
impacting aerobic fitness, despite actual caloric restriction only reaching ~10% [171]. Caloric 
restriction even enhances sleep quality over a two-year period [172]. Similar to exercise, 
some of the beneficial effect of caloric restriction is can be attributed to AMPK activation 
[119]. 
Another alternative to enhance metabolic fitness may be time-restricted feeding. 
Unfortunately, the research into the effects of time-restricted feeding on human physiology 
has been limited, and the studies that have been carried out have been non-experimental in 
nature. An exception has been a crossover study revealing that patients with T2D lose more 
weight, reduce blood glucose, and enhance insulin sensitivity if they consume a reduced-
calorie diet as two meals in the first half of the day instead of as six meals spread throughout 
the day [173]. The benefits of resistance training are either unaffected [174] or enhanced by 
[175, 176] time-restricted feeding. Research in mice is also promising. Mice with free access 
to a high-fat diet develop impaired metabolic phenotypes, although restricting food access to 
only a few hours a day protects against this [177, 178]. Furthermore, entrainment of the 
circadian rhythm in mice is achieved via caloric restriction or time-restricted feeding alike 
[179]. Most mouse strains used in laboratory settings have no melatonin production or 
function [180]. Since melatonin is a well-conserved circadian hormone whose endogenous 
production is entrained by light exposure, translating circadian research using nocturnal 
rodents with nonoperational melatonin systems to diurnal humans should only be done with 
a great deal of caution. 
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Even if the diet and exercise intervention used in the first paper of this thesis is not the perfect 
means to enhance metabolic fitness or adaptations to exercise, the research was unique since 
it explored how DNA methylation changed in response to fasting between exercise bouts. 
Unfortunately, neither DNA methylation nor other epigenetic modifications were 
characterized in the follow-up research that took place over three weeks of training [166, 
167]. There are only a handful of publications characterizing the DNA methylation response 
to exercise or diet interventions in human skeletal muscle, making this work relatively 
unique. 
 
Figure 5: 
Exercise and Fasting Impact Every Aspect of the “Central Dogma of Biology”. 
 
Research into epigenomic effects of lifestyle modifications in humans is limited due to two 
main factors: financial barriers to conducting the research and an inability to directly tie 
observations to a physiological readout. In the first paper of the thesis, DNA methylation of 
specific target-gene promoters was interrogated, which was not cost-prohibitive. However, 
using techniques to study the entire DNA methylome would have increased the cost of the 
research by at least an order of magnitude. Furthermore, any data retrieved from the 
epigenomic analysis would still have been difficult to tie to the other readouts of the research 
in a mechanistic fashion. Although DNA methylation in a promoter region may lead to 
inhibition of gene transcription, such data can only be correlational without having 
experimental methods to manipulate DNA methylation in vivo. Thus, although the research 
conducted in the first paper of the thesis provided novel insights into epigenetic effects in 
skeletal muscle due to fasting between exercise bouts, the shortage of other similar research 
makes the observations difficult to contextualize. 
In contrast, there is a wealth of information in the scientific literature regarding how exercise 
influences AMPK functionality. The second paper of the thesis adds to this body of research 
by exposing a role for AMPK activity in the dephosphorylation and inhibition of FAK 
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signaling in human skeletal muscle. The final paper reveals a role for AMPK in inhibiting 
GDAP1 gene expression, also in human skeletal muscle. 
4.2 PAPER 2: FAK’S ROLE IN ALTERING SUBSTRATE UTILIZATION HAS 
IMPLICATIONS FOR METABOLIC DISORDER 
Despite FAK being a known mediator of insulin signaling in rodent models and immortalized 
cells [181-189], the influence of insulin stimulation on FAK in human skeletal muscle had 
not been previously described. The second paper of this thesis addresses this gap in the 
literature by revealing that neither primary human skeletal muscle cells, nor insulin-sensitive 
human muscle tissue stimulated ex vivo, have alterations in FAK phosphorylation in response 
to insulin stimulation. 
Furthermore, although FAK activation has been observed due to stretch and unloading-
reloading protocols [190-192], a direct link between AMPK activity and FAK had not been 
previously described. The research in this paper shows that AMPK activation in human 
skeletal muscle reduces FAK phosphorylation and, thus, activation. This research was taken 
a step further and demonstrated that reducing FAK (by silencing its gene, PTK2) leads to 
increased lipid oxidation and reduced glycogen synthesis. 
These findings regarding AMPK regulation of FAK, although from skeletal muscle, may 
have broader implications for cancer therapies. FAK activity is predominantly studied in 
proliferative and invasive cell types, and FAK inhibitors are a strain of pharmaceuticals that 
are at varying stages in clinical trials. Cancer cells are typified by prioritizing glucose 
oxidation over lipid oxidation, a phenomenon known as the Warburg effect, and this is 
hypothesized to be due to insufficient lipid utilization by mitochondria [193]. In this sense, 
cancer can be thought of as a complex condition with characteristics of a metabolic disorder, 
since cancer cells have altered metabolic flexibility. That FAK knockdown in skeletal muscle 
cells changes the metabolic preference of cells toward lipid oxidation is remarkable. 
Intriguingly, metformin, a drug prescribed to treat T2D patients, activates AMPK and has 
some use in combating cancer progression despite not accumulating in tumorous tissues in 
humans [194]. Furthermore, cancer cells treated with metformin have reduced FAK 
phosphorylation [195, 196].  
The specific manner by which AMPK activity leads to dephosphorylation of FAK is unclear. 
Protein phosphatase 2 and dual-specificity phosphatase (DUSP) may be responsible since 
they can be activated by AMPK [197, 198]. DUSP specifically ought to be examined in future 
research, since FAK inhibitors increase the expression of DUSP1 and DUSP5 [199]. 
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Figure 6: 
AMPK-Mediated FAK Activity and Lipid Oxidation 
Blue arrows indicate activating effects and red diamonds indicate inhibiting effects. 
Solid lines indicate observed effects and dashed lines indicate plausible effects.  
 
These studies indicate that further characterization of the complex interaction of AMPK with 
targets in various tissues will likely lead to discoveries that can inform future treatments for 
chronic diseases typified by metabolic disruption. To this end, the third paper was focused 
on identifying novel candidate genes regulated by AMPK in skeletal muscle. 
4.3 PAPER 3: GDAP1 ALTERS NON-MITOCHONDRIAL METABOLISM 
PRIMARY IN HUMAN SKELETAL MUSCLE 
The bioinformatic analysis identified several candidate genes that may be regulated by AMPK. 
Preliminary experiments validated a role for AMPK in regulation of several of these genes. 
Future research may therefore take this list of genes as a starting point for further exploration. 
Among the candidate genes was GDAP1. Mitochondrial dysfunction as a result of mutations 
in the GDAP1 gene cause a neuromuscular disorder known as Charcot-Marie Tooth syndrome 
[200]. Though the GDAP1 protein also plays a role in insulin signaling in fruit flies [201], its 
role in human skeletal muscle had not been described. Because of its role in both mitochondrial 
function and as a mediator of insulin signaling, GDAP1 was selected for further investigation. 
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Table 4: 
Impact of AMPK Activity on Gene Expression 
Human 
Gene 
Name 
Predicted 
Effect 
Observed in Mouse 
Models (n = 6-8) 
Observed in Primary Human 
Myotubes (n = 3) 
Fasting 
Effect 
Genetic 
Effect 
AAMDC ↓ ↓ ↓ ↓ 
ASPH ↓ ↔ ↑ ↓ 
DPP8 ↓ ↓ ↓ ↓ 
FAM20C ↓ ↓ ↑ ↔ 
GDAP1 ↓ ↓ ↓ ↓ 
GPX3 ↑ ↑ ↑ ↓ 
HHATL ↓ ↓ ↓ Not expressed 
KANSL1L ↓ ↓ ↓ ↓ 
LPIN1 ↑ ↔ ↑ ↑ 
PHLDA3 ↑ ↔ ↑ ↔ 
UGP2 ↑ ↓ ↓ ↓ 
Arrow directions indicate the direction of gene expression change predicted by the 
bioinformatic analysis or observed in the validation experiments. 
Blue and red backgrounds indicate the data from validation experiments supported or were 
contrary to the bioinformatic analysis, respectively. 
 
In skeletal muscle cells, mitochondrial function remains intact when GDAP1 is silenced. This 
is in contrast to nervous tissue, where GDAP1 primarily acts to maintain mitochondrial 
function [200, 202, 203]. Silencing GDAP1 in skeletal muscle cells does not alter glycogen 
synthesis and actually impairs lipid oxidation. The Seahorse metabolic flux analyzer revealed 
that the cells have unaltered mitochondrial oxidation, although non-mitochondrial respiration 
is decreased. Confocal microscopy did not identify differences in mitochondrial networks. 
Thus, the role of GDAP1 in skeletal muscle is to modulate metabolism without affecting 
mitochondrial morphology. 
GDAP1 also induces peroxisomal fragmentation in immortalized fibroblasts [204]. Under 
conditions of metabolic stress, the peroxisomes oxidize lipids in cells [205, 206]. The results 
in the third paper of the thesis suggest a peroxisome-centered role for GDAP1 in human skeletal 
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muscle. In the patients with T2D, increased GDAP1 may be elevated as an adaptive response 
to oxidize lipids, whereas the decrease in non-mitochondrial respiration after GDAP1 silencing 
in primary cells may indicate impaired peroxisomal function. 
It is unclear if the AMPK-mediated reduction in GDAP1 is adaptive. A meta-analysis of 
exercise-responsive genes in humans indicates that GDAP1 is not significantly decreased due 
to exercise [207]. The discovery that AMPK reduces GDAP1 expression in mice and in primary 
skeletal muscle cells is not in direct conflict with these results, since exercise per se involves 
various metabolic and physiological changes above and beyond AMPK activation. It could be 
that AMPK activation in isolation causes a decrease in GDAP1 while the myriad other signals 
induced during exercise override this effect. In this research, GDAP1 levels were not affected 
by exercise in healthy individuals, but were reduced after exercise in T2D patients. This 
bifurcation based on disease status may due to intact AMPK signaling in T2D [121] whereas 
other aspects of their metabolic function are disrupted. 
GDAP1 silencing and AMPK activation affected circadian genes. A role for AMPK in in this 
context has been described [208], but this is the first report implicating GDAP1. Further study 
is needed to resolve the mechanism by which GDAP1 affects core clock machinery. 
4.4 NOVEL EFFECTS OF EXERCISE OR AMPK ACTIVITY IN HUMAN 
SKELETAL MUSCLE- REVISITING THE THESIS AIMS 
The central theory of this thesis work has been that exercise drives beneficial metabolic 
changes in skeletal muscle, in large part due to AMPK activation. To this end, the research 
presented in this thesis demonstrates that: 
1. Combining fasting with exercise enhances AMPK activation and the capacity to 
oxidize lipids in addition to altering the DNA methylation of key genes involved in 
metabolic adaptation to exercise. 
2. Although it is modulated by insulin in other models, insulin stimulation does not alter 
FAK phosphorylation in human skeletal muscle. FAK phosphorylation is, however, 
reduced when AMPK is activated. Furthermore, FAK modulates lipid and 
carbohydrate handling in human skeletal muscle. 
3. AMPK activity inhibits GDAP1 expression in skeletal muscle. While GDAP1 plays 
a role in mitochondrial function in nerve cells, its role in human skeletal muscle is 
apparently non-mitochondrial. Nonetheless, GDAP1 does play a role in lipid 
oxidation, non-mitochondrial respiration, and modulating circadian gene expression. 
This thesis has identified two novel targets of AMPK in human skeletal muscle, FAK and 
GDAP1 gene expression. Additionally, overlaying fasting with exercise leads to 
increased AMPK activation and increased adaptive responses to the exercise. 
The work in this thesis focuses on human skeletal muscle tissue, though exercise affects 
nearly every organ system of the body and AMPK plays a role in maintaining energy 
homeostasis in nearly all cells. A complete picture of how exercise and fasting interact to 
 30 
influence whole-body physiology cannot be developed without future research. 
Specifically, how these lifestyle modifications impact AMPK signaling in liver, brain, 
adipose, and other tissues is required. The research in this thesis provides valuable 
discoveries that help to clarify the physiological and molecular mechanisms responsible 
for exercise- and AMPK-mediated metabolic adaptability. 
 
 
Figure 7: 
Novel Effects of Exercise or AMPK Activation in Human Skeletal Muscle 
Blue arrows indicate activating effects and red diamonds indicate inhibiting effects. 
Solid lines indicate observed effects and dashed lines indicate plausible effects. 
Black dotted lines indicate relationships to be investigated in future research. 
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5 CONCLUSION 
When individuals adopt lifestyle modifications, including diet and exercise, health outcomes 
can be as good as pharmacological interventions in preventing progression to T2D [209, 210]. 
Although exercise as a prescription for good health has a long history, incidences of disorders 
responsive to exercise therapy continue to rise [1, 2]. Although the medical community has 
identified many symptoms that are improved due to exercise training, the specific mechanisms 
responsible for the improvements are incompletely resolved. 
The research in this thesis compliments previous work regarding the benefits of engaging in 
sequential bouts of exercise without nutritional replenishment between. However, this thesis 
pushes the field forward by revealing that DNA methylation is also impacted by the diet and 
exercise protocol used. The papers in this thesis also establish that, despite the presence of a 
vast amount of previous work dissecting the role of AMPK in skeletal muscle, more discoveries 
are left to be made. Specifically, FAK phosphorylation and GDAP1 expression are modulated 
by AMPK activity in skeletal muscle, and silencing either gene alters lipid metabolism. 
To avoid misleading consumers of scientific literature, it is important to recognize and highlight 
the limitations of any given research model. The bulk of the research presented in this thesis is 
novel in that the roles of FAK and GDAP1 in human skeletal muscle had been previously 
undescribed. The previous research that had been done was only performed in simplified 
models (i.e., rodents or immortalized cell systems). Unfortunately, the results from the 
simplified models did not perfectly predict how these proteins behave in human skeletal 
muscle. This thesis provides data more directly relevant to human physiology. 
In addition to physiological research, breakthroughs in the social sciences are needed to address 
the burgeoning problem of metabolic disorders. Even though lifestyle interventions, when 
followed, are effective, most individuals who undertake lifestyle interventions revert to old 
habits, and ultimately regain most of the original weight [211, 212]. Various psychological and 
social barriers prevent would-be beneficiaries from reaping the rewards of lifestyle changes 
[213]. With the advent and popularization of behavioral economics, the field of economics has 
shifted from presuming that individuals act in logical, self-interested, rational manners to 
recognizing that human behavior is not so simply described [214]. Similarly, it is time for the 
medical community to recognize that simple exercise prescriptions will not suffice —no matter 
how logical, self-interested, or rational patients may be. Both physiological research into the 
mechanisms responsible for exercise’s beneficial effects, and social science research into 
motivation and decision-making, are needed to address the burden of metabolic disease. Global 
metabolic health in the 21st century is an interdisciplinary problem that necessitates 
interdisciplinary solutions. 
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